Dual Point-of-care Test for the Diagnosis of Yaws
YARADI
Evaluation of a Rapid Dual Point-of-care Assay for Targeting Antibiotic Treatment for Yaws Eradication: a Prospective Descriptive Study
1 other identifier
observational
703
1 country
2
Brief Summary
A dual POC immunoassay simultaneously detecting non-treponemal and treponemal antibodies was developed for the diagnosis of infections with T. pallidum. The assay is designed for use in resource-limited settings where challenging conditions (such as lack of electricity, running water, or laboratory equipment) commonly exist. We sought to compare performance of the dual-POC assay for diagnosis of yaws infection with that of the RPR and TPHA as reference standards.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2013
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 19, 2013
CompletedFirst Posted
Study publicly available on registry
April 26, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 18, 2014
November 1, 2014
7 months
April 19, 2013
November 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine the accuracy of the dual-test as compared to recognized standard methods
Sensitivity and Specificity as compared to RPR and TPHA 1. Proportion of actual TPHA/RPR positives which are correctly identified as such by DPP (dual-test)T1 and T2 respectively 2. Proportion of TPHA/RPR negatives which are correctly identified as such by DPP (dual-test)T1 and T2 respectively
1 month
Secondary Outcomes (2)
Accuracy of DPP in whole blood and plasma
1 month
Accuracy of DPP determined by Naked eye and Reader
1 month
Study Arms (1)
DPP/RPR-TPHA comparison
The evaluation of T1 (treponemal line) will be conducted by using the T1 positivity identified by naked eye or automated reader to compare with that of TPHA; while the evaluation of T2 (non-treponemal line) will be conducted by using the T2 positivity identified by naked eye, or automatic reader at cut-off value of 20, to compare with the result of RPR.
Eligibility Criteria
Patients will be recruited from Lihir Island villages in April 2013. This community has been described previously. We will conduct community-based surveys and we invited children aged 1 - 15 years suspected to have yaws by clinical examination to participate in the study. All children for whom a parent or guardian gives written informed consent will be included consecutively
You may qualify if:
- Children from 2 to 15 years with clinical suspicion of active yaws
You may not qualify if:
- Persons who are unable to sustain venipuncture; persons who do not provide an informed consent, or withdraw consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oriol Mitjalead
- Papua New Guinea Institute of Medical Researchcollaborator
- Papua New Guinea National Department of Health, Disease Controlcollaborator
- Divine Word Universitycollaborator
- Barcelona Centre for International Health Researchcollaborator
Study Sites (2)
Karkar Island
Marup Village, Madang Province, Papua New Guinea
Lihir Medical Centre
Londolovit, New Ireland Province, 034, Papua New Guinea
Related Publications (1)
Ayove T, Houniei W, Wangnapi R, Bieb SV, Kazadi W, Luke LN, Manineng C, Moses P, Paru R, Esfandiari J, Alonso PL, de Lazzari E, Bassat Q, Mabey D, Mitja O. Sensitivity and specificity of a rapid point-of-care test for active yaws: a comparative study. Lancet Glob Health. 2014 Jul;2(7):e415-21. doi: 10.1016/S2214-109X(14)70231-1. Epub 2014 May 31.
PMID: 25103395DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 19, 2013
First Posted
April 26, 2013
Study Start
April 1, 2013
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
November 18, 2014
Record last verified: 2014-11